Welcome to our dedicated page for Cannae Holdings SEC filings (Ticker: CNNE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannae Holdings, Inc. filings document a NYSE-listed investment holding company with common stock registered under CNNE and portfolio interests in operating businesses. Recent 8-K disclosures cover operating and financial results, shareholder letters, Regulation FD materials such as sum-of-the-parts analysis, annual meeting matters, and capital-structure disclosure.
The filings also record material agreements and financing items, including the termination of a margin loan facility associated with Alight shares held by a Cannae subsidiary. Governance and shareholder-voting disclosures appear alongside exhibits, press releases, and other material-event reports.
Carronade Capital, owning approximately 3.2 million shares of Cannae Holdings, has filed a DFAN14A regarding a proxy contest. The investment firm is pushing for significant board changes and calling for the immediate announcement of the 2025 Annual Meeting date, which has been delayed beyond the usual schedule.
Key concerns raised by Carronade include:
- Criticism of Cannae's delay in scheduling the 2025 Annual Meeting, viewing it as an attempt to manipulate corporate machinery
- Questions about the company's reincorporation from Delaware to Nevada
- Demands for clarity on capital return plans following the Dun & Bradstreet sale
- Request for shareholder-favorable terms in any potential tender offer
Carronade has nominated four independent directors: Mona Aboelnaga, Benjamin Duster, Dennis Prieto, and Cherie Schaible. The firm, managing over $2.3 billion in assets, is led by Dan Gropper and currently holds approximately 3.19 million shares through various entities.